Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical ...
22 hours ago
0
3